HPβCD’s Promise in Treating Ischemic Stroke
Ischemic stroke is a leading cause of mortality and long-term disability worldwide, with limited pharmacological interventions available. 2-hydroxypropyl-β-cyclodextrin (HPβCD), a
Cyclodextrin-Driven Drug Deaggregation
The poor aqueous solubility of niclosamide (Nic), a drug with broad therapeutic potential beyond its original antiparasitic use, presents a
Effect of Microplastics on Cu2+ Adsorption by β-cyclodextrin Modified Biochar
The pervasive co-existence of microplastics with other pollutants complicates the efficacy of adsorbents in water remediation. This study, therefore, investigates
Special Issue of the 21st International Cyclodextrin Symposium
The papers from the Special Issue of the 21st International Cyclodextrin Symposium published in Carbohydrate Polymers are available (https://www.sciencedirect.com/special-issue/10BLTS8S758). The
Hydroxypropyl-Beta-Cyclodextrin (HPBCD) inhibits SARS-CoV-2 replication by modulating intracellular lipid dynamics
A multi-year scientific collaboration between Brasilian and American scientists from Federal University at Rio de Janeiro, Brazil, Laboratory of Immunoregulation,
HPBCD in liquid formulations: a systematic study of physical properties and surfactant compatibility
The researchers of TEVA (USA) explored the role of 2-hydroxypropyl-β-cyclodextrin (HPβCD) as an excipient in liquid formulations by evaluating its
CD-enabled active food packaging in the recent literature
The incorporation of inclusion complexes into films, hydrogels as pads is an effective approach for developing antimicrobial active packaging for
Sulfonated, sulfated thioglycosides and multivalence in heparanase inhibition
Heparan sulfate (HS) analogs are synthetic oligo- and polysaccharides designed to mimic or enhance several biological properties of native HS.
2,6‑di‑O‑methyl‑3‑acetyl‑β‑cyclodextrin: a novel approach to reducde infectivity of SARS‑CoV‑2 and Japanese encephalitis virus
Among 19 CD derivatives studied, pretreatment of viral particles with DMA-β-CyD significantly reduced infectivity (by 2.25–2.67 log₁₀ units after 180
Special issue ‘Responsive nanoparticles in drug delivery systems’
The inclusion of a broad variety of nanomaterials inside drug delivery systems leads to the successful development of hybrid platforms
End of year statistics, 2025
In 2025 three important events were organized on three continents succesfully: The Cyclodextrin News blog published approx. 268 posts in 2024.